A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated WithBRAFMutations-Reference-Cited by-同舟云学术

A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated WithBRAFMutations

Published:2015-11-01 Issue:11 Volume:133 Page:1295
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Larsen Ann-Cathrine¹,Dahmcke Christina M.²,Dahl Christina²,Siersma Volkert D.³,Toft Peter B.⁴,Coupland Sarah E.⁵,Prause Jan U.¹,Guldberg Per²,Heegaard Steffen⁶

Affiliation:

1. Eye Pathology Institute, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark

2. Research Center, Danish Cancer Society, Copenhagen, Denmark

3. Research Unit, Section of General Practice, Institute of Public Health, University of Copenhagen, Copenhagen, Denmark

4. Department of Ophthalmology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark

5. Division of Pathology, Department of Molecular and Clinical Medicine, Royal Liverpool University Hospital, Liverpool, England

6. Eye Pathology Institute, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark4Department of Ophthalmology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conjunctival Melanoma: A Clinical Review and Update;Cancers;2024-09-10

2. Single-cell sequencing depicts tumor architecture and empowers clinical decision in metastatic conjunctival melanoma;Cell Discovery;2024-06-11

3. Artificial intelligence and machine learning a new frontier in the diagnosis of ocular adnexal tumors: A review;SAGE Open Medicine;2024-01

4. Melanocytic lesions of the conjunctiva: an up-to-date review;Diagnostic Histopathology;2024-01

5. Adjuvant Brachytherapy with Ruthenium-106 to Reduce the Risk of Recurrence of Conjunctival Melanoma after Excision;Ocular Oncology and Pathology;2024